miRNA Signatures in Sera of Patients with Active Pulmonary Tuberculosis

Several studies showed that assessing levels of specific circulating microRNAs (miRNAs) is a non-invasive, rapid, and accurate method for diagnosing diseases or detecting alterations in physiological conditions. We aimed to identify a serum miRNA signature to be used for the diagnosis of tuberculosis (TB). To account for variations due to the genetic makeup, we enrolled adults from two study settings in Europe and Africa. The following categories of subjects were considered: healthy (H), active pulmonary TB (PTB), active pulmonary TB, HIV co-infected (PTB/HIV), latent TB infection (LTBI), other pulmonary infections (OPI), and active extra-pulmonary TB (EPTB). Sera from 10 subjects of the same category were pooled and, after total RNA extraction, screened for miRNA levels by TaqMan low-density arrays. After identification of “relevant miRNAs”, we refined the serum miRNA signature discriminating between H and PTB on individual subjects. Signatures were analyzed for their diagnostic performances using a multivariate logistic model and a Relevance Vector Machine (RVM) model. A leave-one-out-cross-validation (LOOCV) approach was adopted for assessing how both models could perform in practice. The analysis on pooled specimens identified selected miRNAs as discriminatory for the categories analyzed. On individual serum samples, we showed that 15 miRNAs serve as signature for H and PTB categories with a diagnostic accuracy of 82% (CI 70.2–90.0), and 77% (CI 64.2–85.9) in a RVM and a logistic classification model, respectively. Considering the different ethnicity, by selecting the specific signature for the European group (10 miRNAs) the diagnostic accuracy increased up to 83% (CI 68.1–92.1), and 81% (65.0–90.3), respectively. The African-specific signature (12 miRNAs) increased the diagnostic accuracy up to 95% (CI 76.4–99.1), and 100% (83.9–100.0), respectively. Serum miRNA signatures represent an interesting source of biomarkers for TB disease with the potential to discriminate between PTB and LTBI, but also among the other categories.

[1]  O. Shaker,et al.  Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia , 2013, Cell Biochemistry and Biophysics.

[2]  Alimuddin Zumla,et al.  Tuberculosis 2013 : 2 Tuberculosis biomarkers discovery : developments , needs , and challenges , 2013 .

[3]  D. Cirillo,et al.  Tuberculosis: lights and shadows in the current diagnostic landscape. , 2013, The new microbiologica.

[4]  Zuhong Lu,et al.  Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection , 2012, BMC Infectious Diseases.

[5]  Yurong Fu,et al.  Altered microRNA Signatures in Sputum of Patients with Active Pulmonary Tuberculosis , 2012, PloS one.

[6]  S. Ayaya,et al.  A Systematic Review of Clinical Diagnostic Systems Used in the Diagnosis of Tuberculosis in Children , 2012, AIDS research and treatment.

[7]  J. O’Grady,et al.  Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. , 2012, The Journal of infectious diseases.

[8]  Uwe Weidner,et al.  Classification in High-Dimensional Feature Spaces—Assessment Using SVM, IVM and RVM With Focus on Simulated EnMAP Data , 2012, IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing.

[9]  Seena K. Ajit.  Circulating microRNAs as Biomarkers, Therapeutic Targets, and Signaling Molecules , 2012, Sensors.

[10]  X. Chen,et al.  Secreted microRNAs: a new form of intercellular communication. , 2012, Trends in cell biology.

[11]  I. Olivier,et al.  A metabolomics approach to characterise and identify various Mycobacterium species. , 2012, Journal of microbiological methods.

[12]  M. Tsolia,et al.  Latent tuberculosis infection in children: diagnostic approaches , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[13]  Angelica Lindlöf,et al.  How to Choose a Normalization Strategy for miRNA Quantitative Real-Time (qPCR) Arrays , 2011, J. Bioinform. Comput. Biol..

[14]  Yurong Fu,et al.  Circulating MicroRNAs in Patients with Active Pulmonary Tuberculosis , 2011, Journal of Clinical Microbiology.

[15]  Qian Gao,et al.  Comparative miRNA Expression Profiles in Individuals with Latent and Active Tuberculosis , 2011, PloS one.

[16]  Nicola J. Armstrong,et al.  Haemolysis during Sample Preparation Alters microRNA Content of Plasma , 2011, PloS one.

[17]  Zhining Wang,et al.  Transcriptional responses of host peripheral blood cells to tuberculosis infection. , 2011, Tuberculosis.

[18]  G. Calin,et al.  MicroRNAs in body fluids—the mix of hormones and biomarkers , 2011, Nature Reviews Clinical Oncology.

[19]  Xinjing Wang,et al.  Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. , 2011, Molecular immunology.

[20]  Alimuddin Zumla,et al.  Immunological biomarkers of tuberculosis , 2011, Nature Reviews Immunology.

[21]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[22]  J. O’Grady,et al.  Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection , 2011, Tropical medicine & international health : TM & IH.

[23]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[24]  P. Davies,et al.  Tuberculosis at extremes of age , 2010, Respirology.

[25]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[26]  Alimuddin Zumla,et al.  Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice , 2010, The Lancet.

[27]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[28]  F. Cobelens,et al.  LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement , 2009, European Respiratory Journal.

[29]  Eric C. Lai,et al.  Biological principles of microRNA-mediated regulation: shared themes amid diversity , 2008, Nature Reviews Genetics.

[30]  Yariv Yogev,et al.  Serum MicroRNAs Are Promising Novel Biomarkers , 2008, PloS one.

[31]  David Masip,et al.  A sparse Bayesian approach for joint feature selection and classifier learning , 2008, Pattern Analysis and Applications.

[32]  B. Marais.  Tuberculosis in children , 2008, Pediatric pulmonology.

[33]  V. Yohai,et al.  High breakdown point robust regression with censored data , 2008, 0803.1736.

[34]  Dirk Repsilber,et al.  Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis , 2007, Journal of Molecular Medicine.

[35]  Paul D van Helden,et al.  Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. , 2007, The Journal of infectious diseases.

[36]  M. Herbster,et al.  Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum , 2006, The Lancet.

[37]  Jin-Wu Nam,et al.  Genomics of microRNA. , 2006, Trends in genetics : TIG.

[38]  P. Good.  Permutation, Parametric, and Bootstrap Tests of Hypotheses , 2005 .

[39]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[40]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[41]  K. Zou,et al.  Smooth non-parametric receiver operating characteristic (ROC) curves for continuous diagnostic tests. , 1997, Statistics in medicine.

[42]  V. Yohai.  HIGH BREAKDOWN-POINT AND HIGH EFFICIENCY ROBUST ESTIMATES FOR REGRESSION , 1987 .

[43]  P. Escalante.  Tuberculosis , 1904, Annals of Internal Medicine.

[44]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[45]  Alberto Izzotti,et al.  MicroRNAs in cancer treatment and prognosis. , 2012, American journal of cancer research.

[46]  D Repsilber,et al.  Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.

[47]  Jason C Hsu,et al.  A Comparison of Normalization Techniques for MicroRNA Microarray Data , 2008, Statistical applications in genetics and molecular biology.

[48]  George Eastman House,et al.  Sparse Bayesian Learning and the Relevance Vector Machine , 2001 .